Worth reading
65In focus
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
67.9
Year-on-year decline in operating profit (%)Wording
Conditional
How definitive the wording is.Results for this period
Full year令和６年６月１日〜令和７年５月31日ConsolidatedJapanese GAAPNet Sales63,508¥ millionYear on year +16.6%Progress 95.1%
Operating profit293¥ millionYear on year -67.9%Progress 26.1%
Ordinary income136¥ millionYear on year -83.6%Progress 14.5%
Net income attributable to owners of the parent-367¥ million
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share△32円48銭
Operating Margin0.5%
Financial position at period-end
Total assets31,924¥ million
of which net assets 6,918 ¥ millionEquity ratio 20.9%vs. prior year-end -3.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+1,311
Investment-4,462
Financials+939
Net change-2,212
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥4,891 million
Segment revenue¥52,625 million (YoY +19.1%), ¥8,696 million (YoY +5.0%), ¥609 million (YoY -8.2%), ¥511 million (YoY +1.1%), ¥1,064 million (YoY +27.5%)
Segment profit¥578 million (YoY -47.3%), ¥-44 million, ¥51 million (YoY -43.4%), ¥103 million (YoY -8.9%), ¥-52 million
Regional salesNo revenue from external customers outside Japan
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥66,795 million (YoY +5.2%)
Operating profit¥1,123 million (YoY +282.2%)
Ordinary income¥941 million (YoY +587.3%)
Net income¥266 million
Annual Dividend Forecast¥20 → ¥14（-30.0%）
Factors Behind Changes in Business Performance
調剤薬局事業のM&Aによる店舗数拡大と物販事業のコンビニエンスストア部門の好調により増収。調剤報酬・薬価改定、原価上昇、人件費上昇、M&Aに伴う費用増加により減益・最終赤字。
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 1 / Company name ｎｅｘｔ ＰＨ株式会社 / Excluded Number of companies 0 / Company name Not disclosed
Material subsequent eventsNot applicable.
Impairment loss¥184 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥2 million, Reversal of provision for store closure losses ¥36 million, Insurance proceeds received ¥43 million, Subsidy Income ¥74 million, Gain on negative goodwill ¥4 million, Other ¥3 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥2 million, Loss on reduction of fixed assets ¥72 million, Impairment Losses ¥184 million, Loss on cancellation of lease agreements ¥22 million, Disaster Losses ¥11 million
Depreciation and amortization¥730 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable Yes / Subject person Analysts and institutional investors
Issued Shares at Period-End12,060,381
Treasury Shares at Period-End699,476
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 令和６年６月１日〜令和７年５月31日 |
| Net Sales | ¥63,508 million (YoY +16.6%) |
| Operating profit | ¥293 million (YoY -67.9%) |
| Ordinary income | ¥136 million (YoY -83.6%) |
| Profit attributable to owners of the parent | ¥-367 million |
| Net income per share | △32円48銭 |
| Operating Margin | 0.5% |
| Equity ratio | End of the current fiscal period 20.9% / End of previous period 24.3% |
| Total assets | ¥31,924 million |
| Net assets | ¥6,918 million |
| Cash flows from operating activities | ¥1,311 million |
| Cash flows from investing activities | ¥-4,462 million |
| Cash flows from financing activities | ¥939 million |
| Cash and cash equivalents at end of period | ¥4,891 million |
| Full-year earnings forecast | Net Sales ¥66,795 million (YoY +5.2%) / Operating profit ¥1,123 million (YoY +282.2%) / Ordinary income ¥941 million (YoY +587.3%) / Net income ¥266 million |
| Annual Dividend Forecast | ¥20 → ¥14（-30.0%） |
| Segment revenue | ¥52,625 million (YoY +19.1%), ¥8,696 million (YoY +5.0%), ¥609 million (YoY -8.2%), ¥511 million (YoY +1.1%), ¥1,064 million (YoY +27.5%) |
| Segment profit | ¥578 million (YoY -47.3%), ¥-44 million, ¥51 million (YoY -43.4%), ¥103 million (YoY -8.9%), ¥-52 million |
| Regional sales | No revenue from external customers outside Japan |
| Depreciation and amortization | ¥730 million |
| Impairment loss | ¥184 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥2 million, Reversal of provision for store closure losses ¥36 million, Insurance proceeds received ¥43 million, Subsidy Income ¥74 million, Gain on negative goodwill ¥4 million, Other ¥3 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥2 million, Loss on reduction of fixed assets ¥72 million, Impairment Losses ¥184 million, Loss on cancellation of lease agreements ¥22 million, Disaster Losses ¥11 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name ｎｅｘｔ ＰＨ株式会社 / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Analysts and institutional investors |
| Issued Shares at Period-End | 12,060,381 |
| Treasury Shares at Period-End | 699,476 |
| Factors Behind Changes in Business Performance | 調剤薬局事業のM&Aによる店舗数拡大と物販事業のコンビニエンスストア部門の好調により増収。調剤報酬・薬価改定、原価上昇、人件費上昇、M&Aに伴う費用増加により減益・最終赤字。 |
Items this document does not state (4)
Revision to Earnings ForecastPayout ratioShareholder Return PolicyOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.売上高は、調剤薬局事業のM&Aによる店舗数拡大に伴う調剤売上高の増加と、物販事業のコンビニエンスストア部門の好調により増加した。利益面は、調剤報酬・薬価改定、仕入環境の変動による原価上昇、給与水準引き上げによる人件費上昇、M&Aに伴う費用増加が要因となった。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.